AC
GOSS icon

AlphaCore Capital’s Gossamer Bio GOSS Stock Holding History

AlphaCore Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4K Buy
53,011
+26,634
+101% +$41.9K ﹤0.01% 1083
2025
Q4 		$81.8K Buy
+26,377
New +$75.3K ﹤0.01% 1117

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

AlphaCore Capital's GOSS Position: Q1 2026 in Review

AlphaCore Capital increased its Gossamer Bio (GOSS) stake by 101% in Q1 2026, buying an estimated $41.9K and bringing the position to 53,011 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

AlphaCore Capital first reported a position in GOSS in Q4 2025 and has held it in 2 quarters since. The position peaked at $81.8K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • AlphaCore Capital held 53,011 shares of Gossamer Bio worth $17.4K as of Q1 2026.
  • AlphaCore Capital bought 26,634 Gossamer Bio shares in Q1 2026, an estimated $41.9K.
  • Gossamer Bio made up ﹤0.01% of AlphaCore Capital's portfolio in Q1 2026, its #1083 holding.
  • AlphaCore Capital first reported a position in Gossamer Bio in Q4 2025 and has held it in 2 quarters since.
  • AlphaCore Capital's Gossamer Bio position peaked at $81.8K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.